Study title:
Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. Fan DS, Yu CB, Chiu TY, Wong CY, Ng JS, Pang CP, Lam DS. Arch Ophthalmol. 2003 Dec;121(12):1716-21.Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. Fan DS, Yu CB, Chiu TY, Wong CY, Ng JS, Pang CP, Lam DS. Arch Ophthalmol. 2003 Dec;121(12):1716-21.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Eye Diseases
|
Brands: Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: RIMEXOLONE |
ATC code: SO1BA13
|
Document link:
Ocular-hypertensive and anti-inflammatory response to rimexo.pdf
|
Document date: 2011-09-06
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|